Status:
COMPLETED
Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines
Lead Sponsor:
Allergan
Conditions:
Skin Aging
Eligibility:
FEMALE
35-55 years
Phase:
PHASE4
Brief Summary
This study evaluates the patient satisfaction and onset of effect following treatment with botulinum toxin Type A in the treatment of glabellar rhytids (frown lines)
Eligibility Criteria
Inclusion
- Female subjects of any race, 35-55 years of age
- Moderate to severe glabellar wrinkles (lines between the eyebrows)
Exclusion
- Previous botulinum toxin therapy
- Subjects who are pregnant, breast-feeding, or who are of childbearing potential and not practicing a reliable method of birth control
- Subjects planning a facial cosmetic procedure or visible scars
- Previous cosmetic surgery to the upper face
- Medical condition that may increase their risk of exposure to botulinum toxin including diagnosed Myasthenia Gravis, Eaton-Lambert Syndrome, Amyotrophic Lateral Sclerosis, or any other disease that might interfere with neuromuscular function
- History of facial nerve palsy
- Allergy or sensitivity to any component of the study medication
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00856414
Start Date
March 1 2009
End Date
April 1 2009
Last Update
January 29 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
West Palm Beach, Florida, United States
2
Livonia, Michigan, United States